Cocrystal Pharma, Inc. (COCP) shareholders
Close on Nov 17, 2026Market cap $19.46MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Opko Health, Inc. Joint filing with Frost Phillip Md Et Al (13.90%), Frost Gamma Investments Trust (13.60%) | 5,692,916 | 29.60% | 13D (active) amendment | Nov 4, 2026 |
| Phillip Frost, M.D. Joint filing with Frost Gamma Investments Trust (13.50%) | 2,784,719 | 13.90% | 13D (active) amendment | Aug 3, 2026 |
| Sabby Volatility Warrant Master Fund, Ltd. | – | – | 13G (passive) amendment | Dec 31, 2023 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of COCP | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 358,228 | 1.86% | $376.14K | +118,257 | 0.00% |
| Renaissance Technologies LLC | 179,628 | 0.93% | $188.61K | +55,700 | 0.00% |
| Two Sigma Investments, LP | 175,379 | 0.91% | $184.15K | New | 0.00% |
| Geode Capital Management, LLC | 76,208 | 0.40% | $80.03K | −14,023 | 0.00% |
| BlackRock, Inc. | 73,746 | 0.38% | $77.43K | – | 0.00% |
| Citadel Advisors LLC | 45,118 | 0.23% | $47.37K | New | 0.00% |
| Neuberger Berman Group LLC | 31,886 | 0.17% | $33.48K | – | 0.00% |
| XTX Topco Ltd | 29,342 | 0.15% | $30.81K | −6,689 | 0.00% |
| Jane Street Group, LLC | 25,761 | 0.13% | $27.05K | +13,050 | 0.00% |
| Vanguard Fiduciary Trust Co | 24,016 | 0.12% | $25.22K | – | 0.00% |
| State Street Corp | 20,543 | 0.11% | $21.57K | – | 0.00% |
| Hrt Financial LP | 20,336 | 0.11% | $21.00K | New | 0.00% |
| Parallel Advisors, LLC | 12,569 | 0.07% | $13.20K | – | 0.00% |
| Northern Trust Corp | 11,921 | 0.06% | $12.52K | – | 0.00% |
| Ground Swell Capital, LLC | 10,752 | 0.06% | $11.29K | New | 0.01% |
| Wells Fargo & Company/Mn | 6,257 | 0.03% | $6.57K | −782 | 0.00% |
| UBS Group AG | 4,133 | 0.02% | $4.34K | −511 | 0.00% |
| Tower Research Capital LLC (TRC) | 3,984 | 0.02% | $4.18K | −264 | 0.00% |
| Morgan Stanley | 871 | 0.00% | $915 | −77 | 0.00% |
| Northwestern Mutual Wealth Management Co | 817 | 0.00% | $858 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 27 | 1M | 5.8% | 7 / 3 | 7 / 6 | 0M | 0M |
| Q1 2026 | 26 | 1M | 4.0% | 4 / 6 | 4 / 4 | 0M | 0M |
| Q4 2025 | 28 | 1M | 4.0% | 7 / 3 | 9 / 1 | 0M | 0M |
| Q3 2025 | 22 | 1M | 3.5% | 4 / 3 | 5 / 4 | 0M | 0M |
| Q2 2025 | 22 | 1M | 3.6% | 1 / 6 | 4 / 3 | 0M | 0M |
| Q1 2025 | 24 | 1M | 3.9% | 2 / 5 | 5 / 2 | 0M | 0M |
| Q4 2024 | 24 | 1M | 3.7% | 5 / 4 | 5 / 1 | 0M | 0M |
| Q3 2024 | 20 | 1M | 3.7% | 7 / 4 | 2 / 0 | 0M | 0M |
| Q2 2024 | 14 | 1M | 3.5% | 1 / 3 | 6 / 3 | 0M | 0M |
| Q1 2024 | 16 | 1M | 4.4% | 0 / 8 | 3 / 1 | 0M | 0M |
| Q4 2023 | 17 | 1M | 3.9% | 2 / 4 | 4 / 1 | 0M | 0M |
| Q3 2023 | 16 | 1M | 3.7% | 0 / 6 | 3 / 4 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
6 funds held COCP in Q2 2026, 83% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of COCP | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 187,266 | 0.97% | $196.63K | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 170,962 | 0.89% | $179.51K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 49,807 | 0.26% | $55.78K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 9,629 | 0.05% | $10.78K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 8,526 | 0.04% | $9.55K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 6,122 | 0.03% | $6.86K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| James Sapirstein | Chief Executive Officer | – | – | Jun 3, 2026 |
| James Joseph Martin | Co-CEO and CFO | 44,167 | 0.23% | Jan 13, 2026 |
| Sam Lee | President and Co-CEO | 76,355 | 0.40% | Jan 13, 2026 |
| Carol L. Brosgart | Director | – | – | Aug 21, 2026 |
| Phillip Md Et Al Frost | Director, 10% owner | 2,020,651 | 10.49% | Aug 6, 2026 |
| Anthony J. Japour | Director | 14,924 | 0.08% | Jan 13, 2026 |
| Fred Hassan | Director | 1,383,009 | 7.18% | Jan 13, 2026 |
| Richard C. Pfenniger Jr | Director | 31,400 | 0.16% | Jan 13, 2026 |
| Roger D. Kornberg | Director | 67,878 | 0.35% | Jan 13, 2026 |
| Steven D. Rubin | Director | 7,206,235 | 37.41% | Jan 13, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Phillip Md Et Al Frost Director, 10% owner | Aug 5, 2026 | Buy | +10,000 | $0.98 | $9.80K | 1,993,551 |
| Phillip Md Et Al Frost Director, 10% owner | Aug 3, 2026 | Buy | +75,000 | $0.94 | $70.50K | 1,983,551 |
| Phillip Md Et Al Frost Director, 10% owner | Feb 24, 2026 | Buy | +20,000 | $1.00 | $20.00K | 1,908,551 |
| Phillip Md Et Al Frost Director, 10% owner | Feb 6, 2026 | Buy | +50,000 | $0.95 | $47.50K | 1,888,551 |
| Phillip Md Et Al Frost Director, 10% owner | Dec 31, 2025 | Buy | +50,000 | $0.95 | $47.50K | 1,838,551 |
| Phillip Md Et Al Frost Director, 10% owner | Dec 30, 2025 | Buy | +20,000 | $0.97 | $19.40K | 1,788,551 |
| Phillip Md Et Al Frost Director, 10% owner | Dec 26, 2025 | Buy | +40,000 | $0.97 | $38.80K | 1,768,551 |
| Phillip Md Et Al Frost Director, 10% owner | Dec 24, 2025 | Buy | +25,000 | $0.97 | $24.25K | 1,728,551 |
| Phillip Md Et Al Frost Director, 10% owner | Nov 26, 2025 | Buy | +1,500 | $1.00 | $1.50K | 1,701,051 |
| Phillip Md Et Al Frost Director, 10% owner | Nov 26, 2025 | Buy | +2,500 | $0.99 | $2.48K | 1,703,551 |
| Phillip Md Et Al Frost Director, 10% owner | Nov 25, 2025 | Buy | +20,000 | $0.94 | $18.80K | 1,699,551 |
| Phillip Md Et Al Frost Director, 10% owner | Oct 28, 2025 | Award | +359,713 | $1.39 | $500.00K | 1,679,551 |
| Richard C. Pfenniger Jr Director | Oct 28, 2025 | Award | +20,000 | – | – | 31,400 |
| Fred Hassan Director | Oct 28, 2025 | Award | +359,713 | $1.39 | $500.00K | 1,383,009 |
| James Joseph Martin Co-CEO and CFO | Oct 28, 2025 | Award | +3,598 | $1.39 | $5.00K | 44,167 |
| Sam Lee President and Co-CEO | Oct 9, 2024 | Award | +40,000 | – | – | 76,355 |
| James Joseph Martin Co-CEO and CFO | Oct 9, 2024 | Award | +40,000 | – | – | 40,569 |
| Fred Hassan Director | Oct 9, 2024 | Award | +8,067 | – | – | 1,023,296 |
| Steven D. Rubin Director | Oct 9, 2024 | Award | +18,957 | – | – | 2,660,242 |
| Phillip Md Et Al Frost Director, 10% owner | Oct 9, 2024 | Award | +27,100 | – | – | 27,100 |
| Roger D. Kornberg Director | Oct 9, 2024 | Award | +28,109 | – | – | 28,109 |
| Anthony J. Japour Director | Oct 9, 2024 | Award | +14,924 | – | – | 14,924 |
| Richard C. Pfenniger Jr Director | Oct 9, 2024 | Award | +8,067 | – | – | 11,400 |
| Phillip Md Et Al Frost Director, 10% owner | Apr 4, 2023 | Buy | +1,015,229 | $1.97 | $2.00M | 1,319,838 |
| Richard C. Pfenniger Jr Director | Aug 20, 2021 | Buy | +40,000 | $1.03 | $41.20K | 40,000 |
| Raymond F. Schinazi 10% owner | May 4, 2021 | Sale | −575,000 | $2.95 | $1.70M | 7,674,960 |
| Raymond F. Schinazi 10% owner | Oct 25, 2019 | Buy | +7,906 | $1.15 | $9.09K | 9,257,863 |
| Raymond F. Schinazi 10% owner | Oct 24, 2019 | Buy | +5,094 | $1.15 | $5.86K | 9,249,957 |
| Raymond F. Schinazi 10% owner | Oct 23, 2019 | Buy | +3,935 | $1.04 | $4.09K | 9,244,863 |
| Raymond F. Schinazi Director, 10% owner | May 10, 2018 | Option exercise | +263,158 | $1.90 | $500.00K | 985,384 |
| Raymond F. Schinazi Director, 10% owner | May 10, 2018 | Award | +10,209 | $1.90 | $19.40K | 995,593 |
| Raymond F. Schinazi Director, 10% owner | May 3, 2018 | Award | +420,737 | $1.90 | $799.40K | 722,226 |
| Phillip Md Et Al Frost Director, 10% owner | May 3, 2018 | Award | +105,263 | $1.90 | $200.00K | 3,655,265 |
| Raymond F. Schinazi Director, 10% owner | Jul 11, 2017 | Option exercise | +1,706,978 | $0.05 | $85.35K | 277,227,831 |
| Raymond F. Schinazi Director, 10% owner | Apr 20, 2017 | Award | +4,166,667 | $0.24 | $1.00M | 9,044,717 |
| Sam Lee PRESIDENT | Dec 23, 2016 | Sale | −2,200,000 | $0.44 | $968.00K | 13,087,847 |
| Gary Wilcox INTERIM CEO, Director | Sep 1, 2016 | Buy | +10,000 | $0.41 | $4.10K | 16,948,605 |
| Raymond F. Schinazi Director, 10% owner | Sep 1, 2016 | Buy | +4,878,050 | $0.41 | $2.00M | 4,878,050 |
| David S. Block Director | Sep 1, 2016 | Buy | +10,000 | $0.41 | $4.10K | 168,696 |
| Steven D. Rubin Director | Mar 15, 2016 | Buy | +39,216 | $0.51 | $20.00K | 733,484 |
| David S. Block Director | Mar 15, 2016 | Buy | +50,000 | $0.51 | $25.50K | 158,696 |
| Jane Ph D. Hsiao Director | Mar 15, 2016 | Buy | +1,235,294 | $0.51 | $630.00K | 3,435,294 |
| Phillip Md Et Al Frost Director, 10% owner | Mar 15, 2016 | Buy | +2,941,177 | $0.51 | $1.50M | 106,500,147 |
| Jeffrey A. Meckler CHIEF EXECUTIVE OFFICER, Director | Mar 15, 2016 | Buy | +294,118 | $0.51 | $150.00K | 657,161 |
| Steven D. Rubin Director | Mar 15, 2016 | Buy | +39,216 | $0.51 | $20.00K | 93,564 |
| Raymond F. Schinazi Director, 10% owner | Mar 15, 2016 | Buy | +2,941,176 | $0.51 | $1.50M | 275,520,853 |
| Gary Wilcox Director | Mar 15, 2016 | Buy | +49,020 | $0.51 | $25.00K | 16,938,605 |
| Jeffrey A. Meckler CHIEF EXECUTIVE OFFICER, Director | Dec 23, 2015 | Buy | +100,000 | $0.58 | $58.00K | 363,043 |
| Raymond F. Schinazi Director, 10% owner | Apr 21, 2015 | Buy | +3,464,855 | $0.92 | $3.19M | 272,579,677 |
| Jeffrey A. Meckler Director | Mar 25, 2015 | Buy | +163,043 | $0.92 | $150.00K | 263,043 |
| Steven D. Rubin Director | Mar 25, 2015 | Buy | +54,348 | $0.92 | $50.00K | 694,268 |
| David S. Block Director | Mar 25, 2015 | Buy | +108,696 | $0.92 | $100.00K | 108,696 |
| Gamma Investments Trust Frost 10% owner | Mar 25, 2015 | Buy | +3,464,855 | $0.92 | $3.19M | 103,558,969 |
| Jane Ph D. Hsiao Director | Mar 25, 2015 | Buy | +2,200,000 | $0.92 | $2.02M | 2,200,000 |
| Gary Wilcox CHIEF EXECUTIVE OFFICER, Director | Mar 25, 2015 | Buy | +54,348 | $0.92 | $50.00K | 16,889,585 |
| Phillip Md Et Al Frost Director, 10% owner | Mar 3, 2015 | Option exercise | +87,726,389 | – | – | 100,094,114 |
| Jane Ph D. Hsiao Director | Mar 3, 2015 | Option exercise | +5,496,654 | – | – | 5,496,654 |
| Raymond F. Schinazi Director, 10% owner | Mar 3, 2015 | Option exercise | +269,114,822 | – | – | 269,114,822 |
| Sam Lee PRESIDENT | Mar 3, 2015 | Option exercise | +15,287,847 | – | – | 15,287,847 |
| Gary Wilcox CHIEF EXECUTIVE OFFICER, Director | Mar 3, 2015 | Option exercise | +16,835,237 | – | – | 16,835,237 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Cocrystal Pharma's stock actually held short. Settlement fails (shares not delivered on time) peaked at 7,479 shares on Sep 3, 2026 over the last 90 days.
See a number that looks wrong?